Celine Halioua
Founder & CEO
Loyal
Celine Halioua is the Founder and CEO of Loyal, a clinical-stage animal health company
developing the first longevity drugs for dogs. Since founding Loyal in 2019, she has raised over $150M and has led the company through several historic regulatory milestones, including earning what is believed to be the first- and second-ever acceptances from the FDA that a drugcould be effectively developed for lifespan extension.
Prior to Loyal, Celine was Chief of Staff at the Longevity Fund and pursued a DPhil in the
economics of healthcare at Oxford University. She holds a B.S. in neuroscience from the
University of Texas at Austin.
Dain Clare
Vice President
NovaQuest Capital Management
Denise Bevers
President & CEO
VETmAb Biosciences, Inc
Brian Cassell
CEO
Vane
Steve Merchant
Managing Director
Virtual Vet Nurse
Greg Geckles
VP, Market Insights
Independence Pet Holdings
Betsy Watkins
Senior Director, Business Development
Pegasus Laboratories, Inc. (PRN Pharmacal)
Ester Banque
Executive Vice President & President, U.S. Operations
Zoetis
